CollPlant Biotechnologies Ltd. revenue for the last year amounted to 515.00 k USD, the most of which — 515.00 k USD — came from its highest performing source at the moment, Regenerative and Aesthetic Medicine Goods, the year earlier bringing 959.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought CollPlant Biotechnologies Ltd. 484.00 k USD, and the year before that — 10.84 M USD.